<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Ishares Asia 50 Etf — News on 6ix</title>
    <link>https://6ix.com/company/ishares-asia-50-etf</link>
    <description>Latest news and press releases for Ishares Asia 50 Etf on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Thu, 02 Apr 2026 04:00:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/ishares-asia-50-etf" rel="self" type="application/rss+xml" />
    <item>
      <title>BrightSpire Capital, Inc. Announces First Quarter 2026 Earnings Release and Conference Call Dates</title>
      <link>https://6ix.com/company/ishares-asia-50-etf/news/brightspire-capital-inc-announces-first-quarter-2026-earnings-release-and-conference-call-dates-38</link>
      <guid isPermaLink="true">https://6ix.com/company/ishares-asia-50-etf/news/brightspire-capital-inc-announces-first-quarter-2026-earnings-release-and-conference-call-dates-38</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>NEW YORK--(BUSINESS WIRE)-- BrightSpire Capital, Inc. (NYSE: BRSP) (“BrightSpire Capital” or the “Company”) today announced it will release first quarter</description>
    </item>
    <item>
      <title>Ultragenyx Announces U.S. FDA Acceptance of BLA Resubmission for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)</title>
      <link>https://6ix.com/company/ishares-asia-50-etf/news/ultragenyx-announces-us-fda-acceptance-of-bla-resubmission-for-ux111-aav-gene-therapy-to-treat-sanfilippo-syndrome-type-a-mps-iiia-10</link>
      <guid isPermaLink="true">https://6ix.com/company/ishares-asia-50-etf/news/ultragenyx-announces-us-fda-acceptance-of-bla-resubmission-for-ux111-aav-gene-therapy-to-treat-sanfilippo-syndrome-type-a-mps-iiia-10</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>If approved, UX111 will be the first approved therapy for the treatment of Sanfilippo syndrome Type A, a rare disease affecting young children that leads to</description>
    </item>
    <item>
      <title>SurgePays Launches Stored Value and Loyalty Platform Across Retail Network</title>
      <link>https://6ix.com/company/ishares-asia-50-etf/news/surgepays-launches-stored-value-and-loyalty-platform-across-retail-network-3</link>
      <guid isPermaLink="true">https://6ix.com/company/ishares-asia-50-etf/news/surgepays-launches-stored-value-and-loyalty-platform-across-retail-network-3</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>New Platform Capabilities Designed to Increase Revenue Per Store and Further Integrate SurgePays into Core Merchant Operations BARTLETT, Tenn., April 02, 2026</description>
    </item>
    <item>
      <title>Olenox Announces Results of Annual Stockholder Meeting</title>
      <link>https://6ix.com/company/ishares-asia-50-etf/news/olenox-announces-results-of-annual-stockholder-meeting-27</link>
      <guid isPermaLink="true">https://6ix.com/company/ishares-asia-50-etf/news/olenox-announces-results-of-annual-stockholder-meeting-27</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>CONROE, TX / ACCESS Newswire / April 2, 2026 / Olenox Industries, Inc. (NASDAQ:OLOX) (&quot;Olenox&quot; or the &quot;Company&quot;) is pleased to announce the results of its</description>
    </item>
    <item>
      <title>Biodexa Announces Partnership with Syngene To Manufacture MTX240 GMP Clinical Trial Supplies</title>
      <link>https://6ix.com/company/ishares-asia-50-etf/news/biodexa-announces-partnership-with-syngene-to-manufacture-mtx240-gmp-clinical-trial-supplies-9</link>
      <guid isPermaLink="true">https://6ix.com/company/ishares-asia-50-etf/news/biodexa-announces-partnership-with-syngene-to-manufacture-mtx240-gmp-clinical-trial-supplies-9</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>April 2, 2026 Biodexa Announces Partnership with Syngene To Manufacture MTX240 GMP Clinical Trial Supplies Biodexa Pharmaceuticals PLC (Nasdaq: BDRX)</description>
    </item>
    <item>
      <title>Intelligent Bio Solutions Completes Clinical Cut-off Study, Advances FDA 510(k) Clinical Program Targeting Multi-Billion-Dollar U.S. Drug Screening Market</title>
      <link>https://6ix.com/company/ishares-asia-50-etf/news/intelligent-bio-solutions-completes-clinical-cut-off-study-advances-fda-510k-clinical-program-targeting-multi-billion-dollar-us-drug-screening-market-8</link>
      <guid isPermaLink="true">https://6ix.com/company/ishares-asia-50-etf/news/intelligent-bio-solutions-completes-clinical-cut-off-study-advances-fda-510k-clinical-program-targeting-multi-billion-dollar-us-drug-screening-market-8</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>Study results finalized on schedule support FDA clearance and planned U.S. commercial launch Company advances second phase of clinical program for 510(k)</description>
    </item>
    <item>
      <title>Zoetis to Host Webcast and Conference Call on First Quarter 2026 Financial Results</title>
      <link>https://6ix.com/company/ishares-asia-50-etf/news/zoetis-to-host-webcast-and-conference-call-on-first-quarter-2026-financial-results-36</link>
      <guid isPermaLink="true">https://6ix.com/company/ishares-asia-50-etf/news/zoetis-to-host-webcast-and-conference-call-on-first-quarter-2026-financial-results-36</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>PARSIPPANY, N.J.--(BUSINESS WIRE)-- Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, May 7, 2026. Chief</description>
    </item>
    <item>
      <title>Oncotelic Therapeutics Announces Strategic Partnership with TechForce Robotics to Commercialize PDAOAI-Enhanced GMP Robotics Platform</title>
      <link>https://6ix.com/company/ishares-asia-50-etf/news/oncotelic-therapeutics-announces-strategic-partnership-with-techforce-robotics-to-commercialize-pdaoai-enhanced-gmp-robotics-platform-2</link>
      <guid isPermaLink="true">https://6ix.com/company/ishares-asia-50-etf/news/oncotelic-therapeutics-announces-strategic-partnership-with-techforce-robotics-to-commercialize-pdaoai-enhanced-gmp-robotics-platform-2</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>LOS ANGELES, April 02, 2026 (GLOBE NEWSWIRE) -- via IBN -- Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”), a clinical-stage biotechnology company</description>
    </item>
    <item>
      <title>CSW Industrials Increases Quarterly Dividend by 11% to $0.30 Per Share and Repurchases $35M in Shares During the Fiscal Fourth Quarter of 2026</title>
      <link>https://6ix.com/company/ishares-asia-50-etf/news/csw-industrials-increases-quarterly-dividend-by-11percent-to-dollar030-per-share-and-repurchases-dollar35m-in-shares-during-the-fiscal-fourth-quarter-of-2026-12</link>
      <guid isPermaLink="true">https://6ix.com/company/ishares-asia-50-etf/news/csw-industrials-increases-quarterly-dividend-by-11percent-to-dollar030-per-share-and-repurchases-dollar35m-in-shares-during-the-fiscal-fourth-quarter-of-2026-12</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>DALLAS, April 02, 2026 (GLOBE NEWSWIRE) -- CSW Industrials, Inc. (NYSE: CSW) announced today that its Board of Directors has declared a regular quarterly cash</description>
    </item>
    <item>
      <title>Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in New York</title>
      <link>https://6ix.com/company/ishares-asia-50-etf/news/abeona-therapeuticsr-announces-new-qualified-treatment-center-for-zevaskynr-in-new-york-8</link>
      <guid isPermaLink="true">https://6ix.com/company/ishares-asia-50-etf/news/abeona-therapeuticsr-announces-new-qualified-treatment-center-for-zevaskynr-in-new-york-8</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>CLEVELAND, April 02, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced activation of NewYork-Presbyterian/Columbia University</description>
    </item>
    <item>
      <title>Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Application of Dermal Fillers with its Bioneedle Delivery System</title>
      <link>https://6ix.com/company/ishares-asia-50-etf/news/dermata-receives-notice-of-acceptance-of-australian-patent-application-for-topical-application-of-dermal-fillers-with-its-bioneedle-delivery-system-29</link>
      <guid isPermaLink="true">https://6ix.com/company/ishares-asia-50-etf/news/dermata-receives-notice-of-acceptance-of-australian-patent-application-for-topical-application-of-dermal-fillers-with-its-bioneedle-delivery-system-29</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>- This would be Dermata&apos;s first patent, if issued, covering the use of its Bioneedle Delivery System (&quot;BDS&quot;) with dermal fillers -- The Company also has</description>
    </item>
    <item>
      <title>ZenaTech Initiates New Operations in Ukraine to Accelerate Production of Counter-UAS Interceptor Systems</title>
      <link>https://6ix.com/company/ishares-asia-50-etf/news/zenatech-initiates-new-operations-in-ukraine-to-accelerate-production-of-counter-uas-interceptor-systems-10</link>
      <guid isPermaLink="true">https://6ix.com/company/ishares-asia-50-etf/news/zenatech-initiates-new-operations-in-ukraine-to-accelerate-production-of-counter-uas-interceptor-systems-10</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>Ukraine operations will be structured for full regulatory compliance to support U.S. defense and Gulf nation adoptionVANCOUVER, British Columbia, April 02,</description>
    </item>
    <item>
      <title>Quantum BioPharma Wins Significant Court Challenge in USD $700,000,000 Claim as Defendants Joint Motion to Dismiss Lawsuit Alleging Market Manipulation by CIBC World Markets and RBC Dominion Securities is Denied</title>
      <link>https://6ix.com/company/ishares-asia-50-etf/news/quantum-biopharma-wins-significant-court-challenge-in-usd-dollar700000000-claim-as-defendants-joint-motion-to-dismiss-lawsuit-alleging-market-manipulation-by-cibc-world-markets-and-rbc-dominion-securities-is-denied-3</link>
      <guid isPermaLink="true">https://6ix.com/company/ishares-asia-50-etf/news/quantum-biopharma-wins-significant-court-challenge-in-usd-dollar700000000-claim-as-defendants-joint-motion-to-dismiss-lawsuit-alleging-market-manipulation-by-cibc-world-markets-and-rbc-dominion-securities-is-denied-3</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>TORONTO, April 02, 2026 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a</description>
    </item>
    <item>
      <title>Pineapple Financial Deepens Strategic Relationship with Canary Capital</title>
      <link>https://6ix.com/company/ishares-asia-50-etf/news/pineapple-financial-deepens-strategic-relationship-with-canary-capital-27</link>
      <guid isPermaLink="true">https://6ix.com/company/ishares-asia-50-etf/news/pineapple-financial-deepens-strategic-relationship-with-canary-capital-27</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>Appoints Digital Asset Treasury Advisor, Bringing Institutional Portfolio Construction and Capital Strategy Expertise Toronto, Ontario--(Newsfile Corp. -</description>
    </item>
    <item>
      <title>Carpenter Technology Announces Conference Call and Webcast</title>
      <link>https://6ix.com/company/ishares-asia-50-etf/news/carpenter-technology-announces-conference-call-and-webcast-5</link>
      <guid isPermaLink="true">https://6ix.com/company/ishares-asia-50-etf/news/carpenter-technology-announces-conference-call-and-webcast-5</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>PHILADELPHIA, April 02, 2026 (GLOBE NEWSWIRE) -- Carpenter Technology Corporation (NYSE: CRS) plans to host a conference call and webcast on Wednesday, April</description>
    </item>
    <item>
      <title>InterDigital signs license agreement with Buffalo Americas; adds new DTV agreements</title>
      <link>https://6ix.com/company/ishares-asia-50-etf/news/interdigital-signs-license-agreement-with-buffalo-americas-adds-new-dtv-agreements-7</link>
      <guid isPermaLink="true">https://6ix.com/company/ishares-asia-50-etf/news/interdigital-signs-license-agreement-with-buffalo-americas-adds-new-dtv-agreements-7</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>WILMINGTON, Del., April 02, 2026 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq: IDCC), a wireless, video, and AI technology research and development company,</description>
    </item>
    <item>
      <title>Plato Gold Corp. Announces Sale of Timmins-Area Properties to Mayfair Gold Corp.</title>
      <link>https://6ix.com/company/ishares-asia-50-etf/news/plato-gold-corp-announces-sale-of-timmins-area-properties-to-mayfair-gold-corp-2</link>
      <guid isPermaLink="true">https://6ix.com/company/ishares-asia-50-etf/news/plato-gold-corp-announces-sale-of-timmins-area-properties-to-mayfair-gold-corp-2</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>TORONTO, Ontario, April 02, 2026 (GLOBE NEWSWIRE) -- Plato Gold Corp. (TSX-V: PGC) (OTCQB: NIOVF) (Frankfurt: 4Y7 or WKN: A0M2QX) (“Plato” or the “Company”)</description>
    </item>
    <item>
      <title>Onconetix Highlights Realbotix AI Humanoid Robot Delivery Update</title>
      <link>https://6ix.com/company/ishares-asia-50-etf/news/onconetix-highlights-realbotix-ai-humanoid-robot-delivery-update-4</link>
      <guid isPermaLink="true">https://6ix.com/company/ishares-asia-50-etf/news/onconetix-highlights-realbotix-ai-humanoid-robot-delivery-update-4</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>Realbotix Announces Expected Delivery of 19 Robots in March, April, and May 2026 as it Scales Production Capacity; Onconetix recently Entered into a</description>
    </item>
    <item>
      <title>Cycurion Goes on Offense: Initiates Legal Action and Seeks Millions in Damages Against ACCESS Newswire and Those Responsible for Disseminating the Unauthorized and Fraudulent Release</title>
      <link>https://6ix.com/company/ishares-asia-50-etf/news/cycurion-goes-on-offense-initiates-legal-action-and-seeks-millions-in-damages-against-access-newswire-and-those-responsible-for-disseminating-the-unauthorized-and-fraudulent-release-3</link>
      <guid isPermaLink="true">https://6ix.com/company/ishares-asia-50-etf/news/cycurion-goes-on-offense-initiates-legal-action-and-seeks-millions-in-damages-against-access-newswire-and-those-responsible-for-disseminating-the-unauthorized-and-fraudulent-release-3</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>MCLEAN, Va., April 02, 2026 (GLOBE NEWSWIRE) -- Cycurion, Inc. (Nasdaq: CYCU) (“Cycurion” or the “Company”), a trusted leader in IT cybersecurity and</description>
    </item>
    <item>
      <title>Dalrada Technology Group, Inc. Announces Agreement Supporting Ultra-High Temperature Industrial Heat Pump Development</title>
      <link>https://6ix.com/company/ishares-asia-50-etf/news/dalrada-technology-group-inc-announces-agreement-supporting-ultra-high-temperature-industrial-heat-pump-development-17</link>
      <guid isPermaLink="true">https://6ix.com/company/ishares-asia-50-etf/news/dalrada-technology-group-inc-announces-agreement-supporting-ultra-high-temperature-industrial-heat-pump-development-17</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>ESCONDIDO, CA / ACCESS Newswire / April 2, 2026 / Dalrada Technology Group, Inc. (the &quot;Company&quot; or &quot;Dalrada&quot;) (OTCID:DHTI), a leader in advanced climate</description>
    </item>
  </channel>
</rss>